文献
(801～900)801. Mack MJ, Leon MB, Smith CR, et al. PARTNER 1 trial investigators.5-year outcomes of transcatheter aortic valve replacement or surgical
aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;
385: 2477-2484. PMID: 25788234
802. 経カテーテル的大動脈弁置換術関連学会協議会．経カテーテル的大動脈弁置換術実施施設基準．
803. Monin JL, Quéré JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a
multicenter study using dobutamine stress hemodynamics. Circulation 2003; 108: 319-324. PMID: 12835219
804. Levy F, Laurent M, Monin JL, et al. Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and
long-term outcome: a European multicenter study. J Am Coll Cardiol 2008; 51: 1466-1472. PMID: 18402902
805. Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients
and severe left ventricular dysfunction. J Am Coll Cardiol 2002; 39: 1356-1363. PMID: 11955855
806. Bauer F, Coutant V, Bernard M, et al. Patients with severe aortic stenosis and reduced ejection fraction: earlier recovery of left ventricular
systolic function after transcatheter aortic valve implantation compared with surgical valve replacement. Echocardiography 2013; 30:
865-870. PMID: 23489257
807. Pilgrim T, Wenaweser P, Meuli F, et al. Clinical outcome of high-risk patients with severe aortic stenosis and reduced left ventricular
ejection fraction undergoing medical treatment or TAVI. PLoS One 2011; 6:e27556. PMID: 22102909
808. Sannino A, Gargiulo G, Schiattarella GG, et al. Increased mortality after transcatheter aortic valve implantation (TAVI) in patients with
severe aortic stenosis and low ejection fraction: a meta-analysis of 6898 patients. Int J Cardiol 2014; 176: 32-39. PMID: 25042666
809. Eleid MF, Goel K, Murad MH, et al. Meta-Analysis of the Prognostic Impact of Stroke Volume, Gradient, and Ejection Fraction After
Transcatheter Aortic Valve Implantation. Am J Cardiol 2015; 116: 989- 994. PMID: 26195275
810. Stevenson LW, Pagani FD, Young JB, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant
2009; 28: 535-541. PMID: 19481012
811. 日本胸部外科学会．J-MACS Statistical Report（2010年6月-2017年7月）．
812. Tanaka A, Tuladhar SM, Onsager D, et al. The Subclavian Intraaortic Balloon Pump: A Compelling Bridge Device for Advanced Heart
Failure. Ann Thorac Surg 2015; 100: 2151-2157; discussion 2157- 2158. PMID: 26228596
813. Thiele H, Zeymer U, Neumann FJ, et al. IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with
cardiogenic shock. N Engl J Med 2012; 367: 1287-1296. PMID: 22920912
814. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for
treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 2009; 30: 2102-2108. PMID: 19617601
815. Bougouin W, Aissaoui N, Combes A, et al. SDEC Investigators. Post-cardiac arrest shock treated with veno-arterial extracorporeal
membrane oxygenation: An observational study and propensity-score analysis. Resuscitation 2017; 110: 126-132. PMID: 27865776
816. Nichol G, Karmy-Jones R, Salerno C, et al. Systematic review of percutaneous cardiopulmonary bypass for cardiac arrest or cardiogenic
shock states. Resuscitation 2006; 70: 381-394. PMID: 16828957 817. Oshima K, Morishita Y, Hinohara H, et al. Factors for weaning from
a percutaneous cardiopulmonary support system (PCPS) in patients with severe cardiac failure: a comparative study in weaned and
nonweaned patients. Int Heart J 2006; 47: 575-584. PMID: 16960412
818. Combes A, Leprince P, Luyt CE, et al. Outcomes and long-term quality- of-life of patients supported by extracorporeal membrane
oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36: 1404-1411. PMID: 18434909
819. Schmidt M, Burrell A, Roberts L, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-
ECMO (SAVE)-score. Eur Heart J 2015; 36: 2246-2256. PMID:26033984
820. Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist
device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol
2008; 52: 1584-1588. PMID: 19007597
821. Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in
Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 2017;69: 278-287. PMID: 27810347
822. Kinugawa K. How to treat stage D heart failure? - When to implant left ventricular assist devices in the era of continuous flow pumps?
Circ J 2011; 75: 2038-2045. PMID: 21817817
823. Kirklin JK, Pagani FD, Kormos RL, et al. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.
J Heart Lung Transplant 2017; 36: 1080-1086. PMID: 28942782
824. Kyo S, Minami T, Nishimura T, et al. New era for therapeutic strategy for heart failure: destination therapy by left ventricular assist device.
J Cardiol 2012; 59: 101-109. PMID: 22326458
825. Saito S, Matsumiya G, Sakaguchi T, et al. Fifteen-year experience with Toyobo paracorporeal left ventricular assist system. J Artif
Organs 2009; 12: 27-34. PMID: 19330502
826. Sasaoka T, Kato TS, Komamura K, et al. Improved long-term performance of pulsatile extracorporeal left ventricular assist device. J
Cardiol 2010; 56: 220-228. PMID: 20615667
827. Shiga T, Kinugawa K, Hatano M, et al. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left
ventricular assist device implantation. Circ J 2011; 75: 121-128. PMID: 21116070
828. Saito S, Matsumiya G, Sakaguchi T, et al. Risk factor analysis of long-term support with left ventricular assist system. Circ J 2010; 74:
715-722. PMID: 20160393
829. Yoshioka D, Sakaguchi T, Saito S, et al. Predictor of early mortality for severe heart failure patients with left ventricular assist device
implantation: significance of INTERMACS level and renal function. Circ J 2012; 76: 1631-1638. PMID: 22484979
830. Imamura T, Kinugawa K, Shiga T, et al. Novel risk scoring system with preoperative objective parameters gives a good prediction of
1-year mortality in patients with a left ventricular assist device. Circ J 2012; 76: 1895-1903. PMID: 22664936
831. 日本循環器学会，日本心臓血管外科学会．循環器病の診断と治療 に関するガイドライン2013．重症心不全に対する植込型補助人工
832. Estep JD, Starling RC, Horstmanshof DA, et al. ROADMAP Study Investigators. Risk Assessment and Comparative Effectiveness of
Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study. J
Am Coll Cardiol 2015; 66: 1747-1761. PMID: 26483097
833. Nakatani T, Sase K, Oshiyama H, et al. J-MACS investigators. Japanese registry for Mechanically Assisted Circulatory Support: First
report. J Heart Lung Transplant 2017; 36: 1087-1096. PMID:28942783
834. Rose EA, Gelijns AC, Moskowitz AJ, et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart
Failure (REMATCH) Study Group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345:
1435-1443. PMID: 11794191
835. Slaughter MS, Rogers JG, Milano CA, et al. HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular
assist device. N Engl J Med 2009; 361: 2241-2251. PMID:19920051
836. 日本循環器学会心臓移植委員会．心臓移植レシピエントの適応． http://www.j-circ.or.jp/hearttp/HTRecCriteria.html
837. Fukushima N, Ono M, Saiki Y, et al. Registry Report on Heart Transplantation in Japan (June 2016). Circ J 2017; 81: 298-303. PMID:
28070058
838. Stehlik J, Bavaria JE, Bax J, et al. Heart, lung, and vascular registries: Evolving goals, successful approaches, and ongoing innovation. J
Heart Lung Transplant 2016; 35: 1149-1157. PMID: 27772667
839. Inglis SC, Clark RA, Dierckx R, et al. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane
Database Syst Rev 2015: CD007228. pub3. PMID: 26517969
840. Roccaforte R, Demers C, Baldassarre F, et al. Effectiveness of comprehensive disease management programmes in improving clinical
outcomes in heart failure patients. A meta-analysis. Eur J Heart Fail 2005; 7: 1133-1144. PMID: 16198629
841. Tsuchihashi-Makaya M, Matsuo H, Kakinoki S, et al. J-HOMECARE Investigators. Home-based disease management program to improve
psychological status in patients with heart failure in Japan. Circ J 2013; 77: 926-933. PMID: 23502992
842. Kato NP, Kinugawa K, Sano M, et al. How effective is an in-hospital heart failure self-care program in a Japanese setting? Lessons from a
randomized controlled pilot study. Patient Prefer Adherence 2016; 10: 171-181. PMID: 26937177
843. Jonkman NH, Westland H, Groenwold RH, et al. Do Self-Management Interventions Work in Patients With Heart Failure? An Individual
Patient Data Meta-Analysis. Circulation 2016; 133: 1189-1198. PMID: 26873943
844. Otsu H, Moriyama M. Effectiveness of an educational self-management program for outpatients with chronic heart failure. Jpn J Nurs
Sci 2011; 8: 140-152. PMID: 22117578
845. Kato N, Kinugawa K, Nakayama E, et al. Insufficient self-care is an independent risk factor for adverse clinical outcomes in Japanese
patients with heart failure. Int Heart J 2013; 54: 382-389. PMID: 24309448
846. Lainscak M, Blue L, Clark AL, et al. Self-care management of heart failure: practical recommendations from the Patient Care Committee
of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011; 13: 115-126. PMID: 21148593
847. Kato N, Kinugawa K, Ito N, et al. Adherence to self-care behavior and factors related to this behavior among patients with heart failure
in Japan. Heart Lung 2009; 38: 398-409. PMID: 19755190
848. Matsuoka S, Tsuchihashi-Makaya M, Kayane T, et al. Health literacy is independently associated with self-care behavior in patients with
heart failure. Patient Educ Couns 2016; 99: 1026-1032. PMID: 26830514
849. 日本心不全学会．心不全手帳．http://www.asas.or.jp/jhfs/topics/20130301.html
850. Tsuchihashi M, Tsutsui H, Kodama K, et al. Clinical characteristics and prognosis of hospitalized patients with congestive heart failure--a
study in Fukuoka, Japan. Jpn Circ J 2000; 64: 953-959. PMID:11194290
851. Wu JR, Lennie TA, Dekker RL, et al. Medication adherence, depressive symptoms, and cardiac event-free survival in patients with heart
failure. J Card Fail 2013; 19: 317-324. PMID: 23663814
852. Anker SD, Ponikowski P, Varney S, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997; 349:
1050- 1053. PMID: 9107242
853. Kinugasa Y, Kato M, Sugihara S, et al. Geriatric nutritional risk index predicts functional dependency and mortality in patients with heart
failure with preserved ejection fraction. Circ J 2013; 77: 705-711.PMID: 23182759
854. 日本心不全学会ガイドライン委員会．高齢心不全患者の治療に関するステートメント．2016．
855. de Diego C, Vila-Córcoles A, Ochoa O, et al. EPIVAC Study Group. Effects of annual influenza vaccination on winter mortality in elderly
people with chronic heart disease. Eur Heart J 2009; 30: 209-216.PMID: 18997178
856. Evangelista LS, Doering LV, Dracup K. Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure readmissions
among veterans. Am J Cardiol 2000; 86: 1339-1342. PMID:11113409
857. 日本循環器学会．禁煙ガイドライン（2010年改訂版）．http://www.j-circ.or.jp/guideline/pdf/JCS2010murohara.h.pdf
858. Reeves GR, Whellan DJ, Patel MJ, et al. Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60
Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left
Ventricular Ejection Fraction. Am J Cardiol 2016; 117: 1953-1958. PMID: 27156830
859. Tei C, Horikiri Y, Park JC, et al. Acute hemodynamic improvement by thermal vasodilation in congestive heart failure. Circulation 1995;
91: 2582-2590. PMID: 7743620
860. 日本循環器学会．心疾患患者の妊娠・出産の適応、管理に関するガイドライン（2010年改訂版）．
861. Jaarsma T, Dracup K, Walden J, et al. Sexual function in patients with advanced heart failure. Heart Lung 1996; 25: 262-270. PMID:
8836742
862. Mandras SA, Uber PA, Mehra MR. Sexual activity and chronic heart failure. Mayo Clin Proc 2007; 82: 1203-1210. PMID: 17908527
863. Rerkpattanapipat P, Stanek MS, Kotler MN. Sex and the heart: what is the role of the cardiologist? Eur Heart J 2001; 22: 201-208. PMID:
11161931
864. Bocchi EA, Guimarães G, Mocelin A, et al. Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive
heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation
2002; 106: 1097-1103. PMID: 12196335
865. Steinke EE, Wright DW, Chung ML, et al. Sexual self-concept, anxiety, and self-efficacy predict sexual activity in heart failure and
healthy elders. Heart Lung 2008; 37: 323-333. PMID: 18790333
866. Fan H, Yu W, Zhang Q, et al. Depression after heart failure and risk of cardiovascular and all-cause mortality: a meta-analysis. Prev Med
2014; 63: 36-42. PMID: 24632228
867. Kato N, Kinugawa K, Yao A, et al. Relationship of depressive symptoms with hospitalization and death in Japanese patients with heart
failure. J Card Fail 2009; 15: 912-919. PMID: 19944369
868. Beattie J, Goodlin S. Supportive Care in Heart Failure. Oxford University Press, 2008: 286-287.
869. O’Connor CM, Jiang W, Kuchibhatla M, et al. SADHART-CHF Investigators. Safety and efficacy of sertraline for depression in patients
with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am
Coll Cardiol 2010; 56: 692-699. PMID: 20723799
870. Freedland KE, Carney RM, Rich MW, et al. Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A
Randomized Clinical Trial. JAMA Intern Med 2015; 175: 1773-1782.PMID: 26414759
871. Gonçalves-Bradley DC, Lannin NA, Clemson LM, et al. Discharge planning from hospital. Cochrane Database Syst Rev 2016:
CD000313. PMID: 26816297
872. van der Wal MH, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 2008; 125: 203-208.
PMID: 18031843
873. Kitzman DW. Outcomes in patients with heart failure with preserved ejection fraction: it is more than the heart. J Am Coll Cardiol 2012;
59: 1006-1007. PMID: 22402072
874. McAlister FA, Stewart S, Ferrua S, et al. Multidisciplinary strategies for the management of heart failure patients at high risk for
admission: a systematic review of randomized trials. J Am Coll Cardiol 2004; 44: 810-819. PMID: 15312864
875. Holland R, Battersby J, Harvey I, et al. Systematic review of multidisciplinary interventions in heart failure. Heart 2005; 91: 899-906.
PMID: 15958358
876. Fonarow GC. Heart failure disease management programs: not a class effect. Circulation 2004; 110: 3506-3508. PMID: 15583088
877. Powell LH, Calvin JE, Richardson D, et al. HART Investigators. Self-management counseling in patients with heart failure: the heart
failure adherence and retention randomized behavioral trial. JAMA 2010; 304: 1331-1338. PMID: 20858878
878. Galbreath AD, Krasuski RA, Smith B, et al. Long-term healthcare and cost outcomes of disease management in a large, randomized,
community-based population with heart failure. Circulation 2004; 110: 3518-3526. PMID: 15531765
879. Riegel B, Moser DK, Anker SD, et al. State of the science: promoting self-care in persons with heart failure: a scientific statement from
the American Heart Association. Circulation 2009; 120: 1141-1163. PMID: 19720935
880. Ades PA, Keteyian SJ, Balady GJ, et al. Cardiac rehabilitation exercise and self-care for chronic heart failure. JACC Heart Fail 2013; 1:
540-547. PMID: 24622007
881. Davidson PM, Cockburn J, Newton PJ, et al. Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and
improve outcomes in high-risk patients? Eur J Cardiovasc Prev Rehabil 2010; 17: 393-402. PMID: 20498608
882. 後藤葉一．慢性心不全の疾病管理プログラムとしての外来心臓リハビリテーションをどう構築し運営するか？ Heart View 2014; 18:
520-527.
883. 後藤葉一．心不全に対する心臓リハビリテーションと運動療法． 齋藤宗靖，後藤葉一，編．狭心症・心筋梗塞のリハビリテーショ
ン改訂第4版．南江堂 2009: 253-268.
884. World Health Organization. Organization. Global atlas of palliative care at the end of life.（ 2014年1月）
885. Allen LA, Yager JE, Funk MJ, et al. Discordance between patient- predicted and model-predicted life expectancy among ambulatory
patients with heart failure. JAMA 2008; 299: 2533-2542. PMID: 18523222
886. Allen LA, Stevenson LW, Grady KL, et al. Decision making in advanced heart failure: a scientific statement from the American Heart
Association. Circulation 2012; 125: 1928-1952. PMID: 22392529
887. Detering KM, Hancock AD, Reade MC, et al. The impact of advance care planning on end of life care in elderly patients: randomised con
trolled trial. BMJ 2010; 340: c1345. PMID: 20332506
888. 厚生労働省．人生の最終段階における医療の決定プロセスに関するガイドライン（2007年5月，改訂2015年3月）．
889. 日本集中治療学会．Do Not Attempt Resuscitation（DNAR）指示のあり方についての勧告．日集中医誌 2017; 24: 208-209.
890. Qaseem A, Snow V, Shekelle P, et al. Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the
end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008; 148: 141-146. PMID: 18195338
891. Lynn J. Perspectives on care at the close of life. Serving patients who may die soon and their families: the role of hospice and other
services. JAMA 2001; 285: 925-932. PMID: 11180736
892. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College
of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 62: e147-e239. PMID:
23747642
893. 日本循環器学会．循環器病の診断と治療に関するガイドライン2011．循環器疾患における末期医療に関する提言．
894. Gibbs JS, McCoy AS, Gibbs LM, et al. Living with and dying from heart failure: the role of palliative care. Heart 2002; 88 Suppl: ii36-
ii39. PMID: 12213799
895. Krumholz HM, Phillips RS, Hamel MB, et al. Resuscitation preferences among patients with severe congestive heart failure: results
from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation 1998;
98: 648-655. PMID: 9715857
896. Levenson JW, McCarthy EP, Lynn J, et al. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000; 48:
S101-S109. PMID: 10809463
897. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic
obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006;31: 58-69. PMID: 16442483
898. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and
associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527-1537.PMID: 17045884
899. Johnson MJ, McDonagh TA, Harkness A, et al. Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot
study. Eur J Heart Fail 2002; 4: 753-756. PMID: 12453546
900. Williams SG, Wright DJ, Marshall P, et al. Safety and potential benefits of low dose diamorphine during exercise in patients with chronic
heart failure. Heart 2003; 89: 1085-1086. PMID: 12923038
急性･慢性心不全診療ガイドライン（2017年改訂版）
Guidelines for Diagnosis and Treatment of Acute and Chronic Heart Failure
（JCS 2017/JHFS 2017）